123 related articles for article (PubMed ID: 16791761)
21. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
22. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
23. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
24. Transfusion therapy in critically ill children.
Chang TT
Pediatr Neonatol; 2008 Apr; 49(2):5-12. PubMed ID: 18947009
[TBL] [Abstract][Full Text] [Related]
25. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
Schneiderman J; Nugent DJ; Young G
Haemophilia; 2004 Jul; 10(4):347-51. PubMed ID: 15230948
[TBL] [Abstract][Full Text] [Related]
26. Heparin-induced thrombocytopenia in critically ill patients.
Warkentin TE
Semin Thromb Hemost; 2015 Feb; 41(1):49-60. PubMed ID: 25590528
[TBL] [Abstract][Full Text] [Related]
27. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
Carr ME; Martin EJ; Kuhn JG; Ambrose H; Fern S; Bryant PC
Clin Lab; 2004; 50(9-10):529-38. PubMed ID: 15481628
[TBL] [Abstract][Full Text] [Related]
29. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
30. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Weiskopf RB
Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
[TBL] [Abstract][Full Text] [Related]
31. Ongoing NovoSeven trials.
Erhardtsen E
Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
[TBL] [Abstract][Full Text] [Related]
32. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
33. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
Enomoto TM; Thorborg P
Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
[TBL] [Abstract][Full Text] [Related]
34. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
35. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Selleng S; Greinacher A
Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
[TBL] [Abstract][Full Text] [Related]
36. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
37. [Recombinant factor VII activated in non-hemophiliac patients with acute severe hemorrhage in the intensive care unit].
Carrillo-Esper R; Sánchez-Zúñiga Mde J; Elizondo-Argueta S; Visoso-Palacios P; Carrillo-Córdova JR
Gac Med Mex; 2006; 142(5):369-76. PubMed ID: 17128815
[TBL] [Abstract][Full Text] [Related]
38. Recombinant activated factor VII and the anaesthetist.
Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
[TBL] [Abstract][Full Text] [Related]
39. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
Mayer SA
Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
[TBL] [Abstract][Full Text] [Related]
40. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
